She explained that the Certificate of Pharmaceutical Product (CPP), issued in the format recommended by the World Health Organisation (WHO), guarantees the quality of pharmaceutical products and the integrity of the exporting country.

Despite efforts to ensure product quality, many counterfeit pharmaceutical products (CPPs) arriving in Nigeria are fake, lamented the speaker.

She stressed NAFDAC’s commitment to stringent regulatory measures, including blacklisting non-compliant companies and taking swift action against those compromising product quality.

Adeyeye affirmed that NAFDAC is actively combating substandard and falsified medicines through prevention, detection, and response strategies.